{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihsm3vf3zklfmxa5y3qbi4dtll7jwb2vlcwahdvz6bwxwip723q7a",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhum6ipqv3u2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/03/24/trump-drug-pricing-flaw-gilead-buys-ouro/?utm_campaign=rss",
  "publishedAt": "2026-03-24T13:17:03.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Comments from a top Trump administration health official add to signs of a major flaw in the president’s most-favored nation drug pricing plans",
  "title": "STAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more",
  "updatedAt": "2026-03-24T13:17:07.000Z"
}